NUTX
Nutex Health·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 4
Bearish signal 0
Stock Price Surged Significantly
Significant Net Income Growth
High Cash/net Profit Ratio
Revenue Beats Expectation
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About NUTX
Nutex Health Inc.
A provider of healthcare services, operating a network of micro-hospitals and clinics in the US
Healthcare Providers and Services
--
04/04/2022
NASDAQ Stock Exchange
800
12-31
Common stock
6030 S. Rice Ave, Suite C, Houston, Texas 77081
--
Nutex Health Inc., is incorporated in Delaware. The company is a leading technology-enabled, risk-taking population health management company that provides advanced cloud-based platforms that enable healthcare organizations to provide value-based care and population health management. The Nutex platform aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of each patient and provider and insight into the patient population. The company also owns and operates a provider network of 141 primary care physicians and more than 600 specialists with 22,000 patients in Los Angeles, CA, and has invested in a responsible health care organization in South Florida with 15,600 Medicare patients through a network of 65 providers.
Earnings Call
Q2/2025
Estimate EPS-5.43
Actual EPS-2.95
Estimate Revenue221.93M
Actual Revenue243.99M
Nutex Health's Q2 2025: Contradictions Emerge on Financial Forecasting, Revenue Recognition, and Expansion Plans
Aug 25,2025 06:53
Earnings Decrypt
Earnings Decrypt
Q3/2025
Estimate EPS1.95
Actual EPS8.27
Estimate Revenue213.81M
Actual Revenue267.80M
Nutex Health's Q3 2025: Contradictions Emerge on IDR Process, Hospital Openings, Inpatient Utilization, and Buyback Plans
Dec 04,2025 04:25
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
NUTX has released its 2025 Q2 earnings. EPS was reported at -2.95, versus the expected -5.43, beating expectations. The chart below visualizes how NUTX has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
NUTX has released its 2025 Q3 earnings report, with revenue of 267.80M, reflecting a YoY change of 239.87%, and net profit of 96.80M, showing a YoY change of 1451.00%. The Sankey diagram below clearly presents NUTX's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
